avanzi in corso la proposta aspire trial non pagato Regan partecipante
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism | NEJM
Aspire
Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial - The Lancet Haematology
Aspire Trial Edition 11.5 - YouTube
ARV-Trials.com
UNITY Biotechnology Begins Phase 2 ASPIRE Trial Administering UBX1325 to Initial Participants with Diabetic Macular Edema
PPT - Aspirin for the prevention of recurrent venous thromboembolism (VTE) after a first PowerPoint Presentation - ID:6798704
ASPIRE-AF - Research Studies - PHRI - Population Health Research Institute of Canada
The ASPIRE Trial: TMC435 in treatment-experienced patients with genotype 1 HCV infection who have failed previous PegIFN/RBV treatment: Week 24 interim analysis